Country Manager Germany - Life Sciences Investment

Country Manager Germany - Life Sciences Investment

Capital Cell | Germany | Full-time

Germany is Europes second-largest healthtech deal market and the only major one with no specialist life sciences investment platform in it. Capital Cell intends to be that platform, and is appointing the person who will build it.

ABOUT CAPITAL CELL

Capital Cell is Europes leading life sciences investment platform. Since 2015 it has completed 163 investment rounds and channelled EUR156 M into biotech, medtech, diagnostics and digital health, with...